You are on page 1of 18

Sales 91% 143% 113% 103% 101% 101% 109% 114% 91%

Expenses 91% 137% 115% 100% 98% 102% 107% 110% 101%
Operating Profit 93% 199% 98% 125% 121% 94% 120% 132% 47%
Net profit -60% -72% 40% 672% 196% 59% 167% 176% 25%
NEULAND LABORATORIES LTD SCREENER.IN

Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Trailing Best Case Worst Case 1.01
Sales 306.73 278.42 396.79 448.23 460.59 465.69 469.15 509.97 578.89 527.41 604.79 604.79 544.02 1.06
Expenses 281.12 254.59 349.30 401.59 402.45 395.40 402.78 430.10 473.20 477.37 553.20 516.63 497.61 1.06
Operating Profit 25.61 23.83 47.49 46.64 58.14 70.29 66.37 79.87 105.69 50.04 51.59 88.16 46.41 1.08
Operating Profit % 8.35 8.56 11.97 10.41 12.62 15.09 14.15 15.66 18.26 9.49 8.53 14.58 8.53 1.01
Other Income 10.53 5.43 2.45 1.67 3.32 3.27 0.44 1.62 1.04 4.36 3.31 - - 0.91
Other Income % 41% 23% 5% 4% 6% 5% 1% 2% 1% 9% 6% 0% 0% 0.84
EBIDT 36.14 29.26 49.94 48.31 61.46 73.56 66.81 81.49 106.73 54.40 54.90 88.16 46.41 1.05
EBIDT % 11.78 10.51 12.59 10.78 13.34 15.80 14.24 15.98 18.44 10.31 9.08 14.58 8.53 0.99
Depreciation 7.37 13.56 15.41 14.89 14.62 14.94 15.32 15.74 19.23 22.10 22.89 22.89 22.89 1.13
Interest 14.36 25.67 29.84 33.27 31.33 24.55 27.35 24.47 21.08 18.92 17.39 17.39 17.39 1.03
Interest Coverage Ratio 1.78 0.93 1.59 1.40 1.86 2.86 2.43 3.26 5.01 2.64 2.97 5.07 2.67 1.04
Profit before tax 14.41 -9.97 4.70 0.18 15.50 34.22 24.48 41.28 66.55 13.54 14.62 47.88 6.13 0.99
Profit before tax % 4.70 -3.58 1.18 0.04 3.37 7.35 5.22 8.09 11.50 2.57 2.42 7.92 1.13 0.94
Tax 2.62 -2.93 -0.37 -1.85 1.86 7.56 8.69 14.86 20.17 1.73 1.03 7% 7% 0.95
Tax % 18.18 29.39 -7.87 -1,027.78 12.00 22.09 35.50 36.00 30.31 12.78 7.05 0.15 1.15 0.96
Net profit 11.79 -7.04 5.07 2.03 13.64 26.67 15.78 26.41 46.38 11.81 13.60 44.51 5.69 1.00
Net profit % 3.84 -2.53 1.28 0.45 2.96 5.73 3.36 5.18 8.01 2.24 2.25 7.36 1.05 0.94
EPS 21.09 -12.59 9.07 3.63 17.40 33.98 17.38 29.10 51.09 13.01 10.60 34.69 4.44 0.95
Price to earning 4.21 -6.64 11.69 18.64 5.68 7.40 21.35 25.40 28.75 56.51 43.05 43.05 22.27 1.33
Price 88.82 83.64 106.03 67.71 98.85 251.39 371.19 739.07 1,468.90 735.23 456.35 1,493.40 98.84 1.26
#DIV/0!
RATIOS: #DIV/0!
Dividend Payout 16.20% 0.00% 0.00% 0.00% 6.82% 8.70% 8.49% 6.78% 0.00% 0.00% 0.00
OPM 8.35% 8.56% 11.97% 10.41% 12.62% 15.09% 14.15% 15.66% 18.26% 9.49% 8.53% 1.01

Price/Sales 28.96%
TRENDS: 10 YEARS 7 YEARS 5 YEARS 3 YEARS RECENT BEST WORST
Sales Growth 6.21% 4.15% 2.75% 3.98% 14.67% 14.67% 2.75%
OPM 12.92% 13.79% 14.59% 14.58% 8.53% 14.58% 8.53%
Price to Earning 22.27 25.85 30.41 38.43 43.05 43.05 22.27
Sales 100% 89% 105% 83% 113% 94% 131%
Expenses 99% 94% 94% 97% 108% 97% 126%
Operating Profit 103% 60% 187% 28% 174% 65% 205%
Net profit 108% 35% 405% 4% 369% 31% 1088%
NEULAND LABORATORIES LTD SCREENER.IN

Narration Jun-16 Sep-16 Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 Mar-18 Jun-18 Sep-18
Sales 149.77 149.59 132.43 139.16 115.40 129.91 121.86 160.23 153.96 168.74
Expenses 125.26 124.43 117.23 110.71 107.34 115.90 112.69 141.44 144.98 154.09
Operating Profit 24.51 25.16 15.20 28.45 8.06 14.01 9.17 18.79 8.98 14.65
Other Income 0.53 -0.01 0.29 0.15 2.56 0.41 1.27 0.29 1.11 0.64
Depreciation 4.36 4.54 4.82 5.07 5.26 5.54 5.70 5.61 5.66 5.92
Interest 6.36 5.49 5.06 4.86 4.51 4.97 4.56 4.88 3.88 4.07
Profit before tax 14.32 15.12 5.61 18.67 0.85 3.91 0.18 8.59 0.55 5.30
Tax 4.81 4.88 1.98 3.98 0.20 1.50 -0.55 0.54 0.14 0.90
Net profit 9.51 10.23 3.63 14.69 0.65 2.40 0.74 8.05 0.41 4.40

OPM 16% 17% 11% 20% 7% 11% 8% 12% 6% 9%


NEULAND LABORATORIES LTD SCREENER.IN

Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
Equity Share Capital 5.47 5.47 5.47 5.47 7.72 7.73 8.95 8.95 8.95 8.95
Reserves 68.43 61.39 66.46 68.49 89.84 113.93 150.10 174.38 532.98 544.99
Total Shareholder Funds 73.90 66.86 71.93 73.96 97.56 121.66 159.05 183.33 541.93 553.94
Borrowings 200.31 233.18 233.75 220.06 210.48 190.10 187.76 182.03 192.11 319.20
Other Liabilities 116.64 97.61 121.67 131.41 135.54 181.86 171.75 163.11 181.38 249.56
Total 390.85 397.65 427.35 425.43 443.58 493.62 518.56 528.47 915.42 1,122.70
Debt/Equity Ratio 2.71 3.49 3.25 2.98 2.16 1.56 1.18 0.99 0.35 0.58
Current Ratio 1.31 1.61 1.51 1.45 1.41 1.20 1.45 1.56 1.81 1.55
Net Block 146.52 162.74 158.30 151.29 135.52 130.85 123.07 138.77 465.55 474.82
Capital Work in Progress 36.80 30.24 27.26 27.15 35.69 34.56 41.47 40.48 19.60 126.09
Investments 7.46 7.67 7.67 7.67 7.64 7.64 7.67 7.55 8.04 8.06
Other Assets 200.07 197.00 234.12 239.32 264.73 320.57 346.35 341.67 422.23 513.73
Total 390.85 397.65 427.35 425.43 443.58 493.62 518.56 528.47 915.42 1,122.70

Working Capital 83.43 99.39 112.45 107.91 129.19 138.71 174.60 178.56 240.85 264.17
Debtors 71.15 72.83 99.57 96.41 98.50 118.59 128.85 119.11 181.11 193.92
Inventory 70.47 71.92 79.92 92.42 92.17 93.42 113.40 126.66 135.11 175.09

Debtor Days 84.67 95.48 91.59 78.51 78.06 92.95 100.25 85.25 114.19 134.20
Inventory Turnover 4.35 3.87 4.96 4.85 5.00 4.98 4.14 4.03 4.28 3.01

Return on Equity 16% -11% 7% 3% 14% 22% 10% 14% 9% 2%


Return on Capital Emp 7% 5% 12% 13% 16% 18% 14% 16% 9% 4%
NEULAND LABORATORIES LTD SCREENER.IN

Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
Cash from Operating Activity 21.61 15.18 32.18 49.22 26.16 48.53 13.07 44.65 38.89 11.52 301.01 0.93
Cash from Investing Activity -74.19 -23.34 -8.07 -5.21 -7.22 -9.78 -14.13 -19.86 -42.11 -116.29 -320.20 1.05
Cash from Financing Activity 53.99 10.31 -24.25 -43.70 -20.16 -38.74 1.15 -23.62 -0.08 104.86 19.76 1.08
Net Cash Flow 1.41 2.15 -0.14 0.31 -1.22 0.01 0.08 1.18 -3.30 0.09 0.57

Net profit 11.79 -7.04 5.07 2.03 13.64 26.67 15.78 26.41 46.38 11.81 152.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.

After customization, you can upload this back on Screener.


Upload on: https://www.screener.in/excel/

Download your customized workbooks now onwards.


Now whenever you will "Export to excel" from Screener, it will export your customized file.

TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: screener.feedback@dalal-street.in
… do ANYTHING.

dalal-street.in
COMPANY NAME NEULAND LABORATORIES LTD
LATEST VERSION 2.10 PLEASE
CURRENT VERSION 2.10

META
Number of shares 1.28
Face Value 10
Current Price 456.35
Market Capitalization 585.49

PROFIT & LOSS


Report Date Mar-09 Mar-10 Mar-11 Mar-12
Sales 306.73 278.42 396.79 448.23
Raw Material Cost 204.73 167.09 254.95 291.94
Change in Inventory 13.86 3.56 3.17 5.16
Power and Fuel 10.81 10.60 13.62 15.84
Other Mfr. Exp 19.02 17.80 17.87 20.57
Employee Cost 20.95 21.91 26.06 30.78
Selling and admin 35.08 34.01 36.45 39.38
Other Expenses 4.39 6.74 3.52 8.24
Other Income 10.53 5.43 2.45 1.67
Depreciation 7.37 13.56 15.41 14.89
Interest 14.36 25.67 29.84 33.27
Profit before tax 14.41 -9.97 4.70 0.18
Tax 2.62 -2.93 -0.37 -1.85
Net profit 11.79 -7.04 5.07 2.03
Dividend Amount 1.91

Quarters
Report Date Jun-16 Sep-16 Dec-16 Mar-17
Sales 149.77 149.59 132.43 139.16
Expenses 125.26 124.43 117.23 110.71
Other Income 0.53 -0.01 0.29 0.15
Depreciation 4.36 4.54 4.82 5.07
Interest 6.36 5.49 5.06 4.86
Profit before tax 14.32 15.12 5.61 18.67
Tax 4.81 4.88 1.98 3.98
Net profit 9.51 10.23 3.63 14.69
Operating Profit 24.51 25.16 15.2 28.45
BALANCE SHEET
Report Date Mar-09 Mar-10 Mar-11 Mar-12
Equity Share Capital 5.47 5.47 5.47 5.47
Reserves 68.43 61.39 66.46 68.49
Borrowings 200.31 233.18 233.75 220.06
Other Liabilities 116.64 97.61 121.67 131.41
Total 390.85 397.65 427.35 425.43
Net Block 146.52 162.74 158.3 151.29
Capital Work in Progress 36.8 30.24 27.26 27.15
Investments 7.46 7.67 7.67 7.67
Other Assets 200.07 197 234.12 239.32
Total 390.85 397.65 427.35 425.43
Receivables 71.15 72.83 99.57 96.41
Inventory 70.47 71.92 79.92 92.42
Cash & Bank 10.62 12.77 4.45 1.78
No. of Equity Shares 5590000 5590000 5590000 5590000
New Bonus Shares
Face value 10 10 10 10

CASH FLOW:
Report Date Mar-09 Mar-10 Mar-11 Mar-12
Cash from Operating Activity 21.61 15.18 32.18 49.22
Cash from Investing Activity -74.19 -23.34 -8.07 -5.21
Cash from Financing Activity 53.99 10.31 -24.25 -43.70
Net Cash Flow 1.41 2.15 -0.14 0.31

PRICE: 88.82 83.64 106.03 67.71

DERIVED:
Adjusted Equity Shares in Cr 0.56 0.56 0.56 0.56
PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18


460.59 465.69 469.15 509.97 578.89 527.41
274.64 246.44 266.42 259.57 270.21 281.09
3.45 -0.13 22.43 6.11 7.31 42.72
18.97 18.31 22.53 22.24 25.78 25.95
24.84 30.12 35.31 30.60 44.90 55.54
34.88 36.26 49.16 59.89 84.92 95.73
41.88 55.62 44.72 58.08 48.36 55.28
10.69 8.52 7.07 5.83 6.34 6.50
3.32 3.27 0.44 1.62 1.04 4.36
14.62 14.94 15.32 15.74 19.23 22.10
31.33 24.55 27.35 24.47 21.08 18.92
15.50 34.22 24.48 41.28 66.55 13.54
1.86 7.56 8.69 14.86 20.17 1.73
13.64 26.67 15.78 26.41 46.38 11.81
0.93 2.32 1.34 1.79

Jun-17 Sep-17 Dec-17 Mar-18 Jun-18 Sep-18


115.40 129.91 121.86 160.23 153.96 168.74
107.34 115.90 112.69 141.44 144.98 154.09
2.56 0.41 1.27 0.29 1.11 0.64
5.26 5.54 5.70 5.61 5.66 5.92
4.51 4.97 4.56 4.88 3.88 4.07
0.85 3.91 0.18 8.59 0.55 5.30
0.20 1.50 -0.55 0.54 0.14 0.90
0.65 2.40 0.74 8.05 0.41 4.40
8.06 14.01 9.17 18.79 8.98 14.65
Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
7.72 7.73 8.95 8.95 8.95 8.95
89.84 113.93 150.1 174.38 532.98 544.99
210.48 190.1 187.76 182.03 192.11 319.2
135.54 181.86 171.75 163.11 181.38 249.56
443.58 493.62 518.56 528.47 915.42 1,122.70
135.52 130.85 123.07 138.77 465.55 474.82
35.69 34.56 41.47 40.48 19.6 126.09
7.64 7.64 7.67 7.55 8.04 8.06
264.73 320.57 346.35 341.67 422.23 513.73
443.58 493.62 518.56 528.47 915.42 1,122.70
98.50 118.59 128.85 119.11 181.11 193.92
92.17 93.42 113.4 126.66 135.11 175.09
0.28 6.68 6.49 9.04 12.04 17.05
7838523 7849223 9076799 9076799 9077799 9077799

10 10 10 10 10 10

Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18


26.16 48.53 13.07 44.65 38.89 11.52
-7.22 -9.78 -14.13 -19.86 -42.11 -116.29
-20.16 -38.74 1.15 -23.62 -0.08 104.86
-1.22 0.01 0.08 1.18 -3.30 0.09

98.85 251.39 371.19 739.07 1,468.90 735.23

0.78 0.78 0.91 0.91 0.91 0.91